How Vystar Corp. Common Stock (OTCMKTS:VYST) Just Caught the Market’s Imagination

How Vystar Corp. Common Stock (OTCMKTS:VYST) Just Caught the Market’s Imagination

SHARE

The week started off with an explosive launch in shares of Vystar Corp. Common Stock (OTCMKTS:VYST). The stock blasted off, powering over 125% higher, making for nearly 2500% in gains over the past month. To further flesh out the story, the company just announced that it is resuming production of the Rx3000, a hybrid air purifier designed by biomedical engineers specifically for hospitals.

According to the release, “The Rx3000 combines powerful germicidal ultraviolet (UV) light with a patented 5-stage HEPA filtration proven in independent EPA- and FDA-certified laboratory testing to destroy on first pass over 99.97% of airborne viruses, bacteria and other contaminants. Vystar acquired the assets and patented intellectual property related to the Rx3000, RxAir, custom filtration and other UV light air purification technologies from UV Flu Technologies in 2018 after production had stopped.”

Vystar Corp. Common Stock (OTCMKTS:VYST) promulgates itself as a company that manufactures and sells Vytex natural rubber latex (NRL) products to the manufacturers of rubber and rubber end products in the United States.

The company owns a technology to produce Vytex NRL, which reduces antigenic protein in natural rubber latex products to virtually undetectable levels in liquid NRL and finished latex products. Its NRL or latex substitutes are used in a range of products, including balloons, textiles, footwear and clothing, adhesives, foams, furniture, carpets, paints, coatings, protective equipment, and sporting equipment, as well as health care products, such as condoms, surgical and exam gloves.

The company was founded in 2000 and is based in Worcester, Massachusetts.

Vytex is currently used in multiple mattress lines, including Natura, and Gold Bond; Jeffco manufactured components for toppers and mattresses, which are sold to multiple manufacturers; and private label toppers, pillows and mattresses sold online via sites such as Amazon and Bed Bath & Beyond. Vytex is also used in industrial adhesives, apparel padding and threads, shoes, sports equipment and electrical gloves and Vytex 3D printed fabrics available through partners like Tami Care. Liquid Vytex can be ordered wholesale through Halcyon Agri’s RCMA and CentroTrade. Vystar continues development of new Vytex formulations and is seeking additional manufacturing and development partners for numerous products.

According to company materials, “Based in Worcester, Mass., Vystar Corp. (OTC Pink: VYST) is the exclusive creator of Vytex Natural Rubber Latex (NRL), a multi-patented, all-natural, raw material that contains significantly reduced levels of the proteins found in natural rubber latex and can be used in over 40,000 products, and the owner of RxAir UV light air purification products. Vytex NRL is a 100% renewable resource, environmentally safe, “green” and fully biodegradable. Vystar is working with manufacturers across a broad range of consumer and medical products bringing Vytex NRL to market in adhesives, gloves, balloons, condoms, other medical devices and natural rubber latex foam mattresses, toppers, and pillows.”

Find out when $VYST reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

As noted above, VYST just announced that it is resuming production of the Rx3000, a hybrid air purifier designed by biomedical engineers specifically for hospitals.

Recent action has seen a bit more than 2500% added to share values of the name over the past month of action. Furthermore, the company has seen a growing influx of trading interest, with the stock’s recent average trading volume running a bit less than 290% over what the stock has registered over the longer term.

“Measles, influenza, strep, MRSA (staph), pneumonia, tuberculosis and other airborne illnesses are a major concern for hospitals and healthcare facilities year round,” stated Bryan Stone, MD, Internal Medicine and Nephrology, Chief of Medicine for Desert Regional Medical Center, and expert consultant for medical application and technology development.  “We believe it is important that hospitals have access to the Rx3000 technology that helps reduce risk of infection from airborne antibiotic-resistant viruses and bacteria.  We also encourage consumers to stay up to date on their vaccinations and follow good hygiene practices by frequently washing their hands with soap and water.”

Currently trading at a market capitalization of $35.41M, VYST has a stash ($191K) of cash on the books, which compares with about $1.9M in total current liabilities. VYST is pulling in trailing 12-month revenues of $256K. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 3373%. As more color becomes clear on the name, we will review the situation and update our take. Sign-up for continuing coverage on shares of $VYST stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in $VYST, either long or short, and we have not been compensated for this article.

Sign Up for our 100% FREE Oracle Dispatch Newsletter